Christina Port

Christina is the CEO of 2NA FISH, a pre-seed startup developing novel cancer diagnostics for making better therapy decisions.
She's amolecular biologist by training, and an entrepreneur at heart. After finishing her PhD in RNA and adipose tissue biology at the Helmholtz Center Munich in 2017, she realized that entrepreneurship lets her provide value to the world more directly than staying in academia. She started 2NA FISH at the LMU in 2020, has since raised more than 1.5 million € in non-dilutive grants and built a team of 6 at 2NA FISH. There, she and her team are working on shifting the paradigm for more data-driven therapy decisions in cancer treatment.